Compare Bandhan Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.41
1.93
NAV
₹9.64
₹429.11
Fund Started
10 Nov 2025
04 Jun 1999
Fund Size
₹279.60 Cr
₹3822.73 Cr
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
-
8.54%
3 Year
-
25.98%
5 Year
-
17.17%
Equity
95.37%
98.53%
Cash
4.60%
1.39%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.56% |
Apollo Hospitals Enterprise Ltd. | 8.22% |
Divi's Laboratories Ltd. | 7.36% |
Max Healthcare Institute Ltd. | 6.93% |
Dr. Reddy's Laboratories Ltd. | 6.75% |
Cipla Ltd. | 6.01% |
JB Chemicals & Pharmaceuticals Ltd. | 5.35% |
Mankind Pharma Ltd. | 3.95% |
Lupin Ltd. | 3.46% |
Ajanta Pharma Ltd. | 3.23% |
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 Nov 2025
04 Jun 1999
